Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature

Immune checkpoint blockade including programmed cell death 1 pathway inhibition with agents such as nivolumab is gaining ground in a wide array of malignancies, so far demonstrating significantly improved survival rates even in metastatic, often multiply pretreated settings. Although targeted in nat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:ESMO Open
Glavni autori: Kastrisiou, Myrto, Kostadima, Fereniki-Lida, Kefas, Aristides, Zarkavelis, George, Kapodistrias, Nikos, Ntouvelis, Evangelos, Petrakis, Dimitrios, Papadaki, Alexandra, Vassou, Amalia, Pentheroudakis, George
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2017
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5640091/
https://ncbi.nlm.nih.gov/pubmed/29067215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2017-000217
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items